Carol joined Syngenta Ventures in 2009 as one of the founding members of the team. Prior to this she was Vice President Ventures Investments at Johnson & Johnson Development Corporation where her focus was on equity investments in pharmaceutical and biotech companies at all stages of development. Previous to this she held a number of senior positions at Clinical Development Capital LLC, a company which provides strategic investment capital to pharmaceutical companies for clinical development, Bristol-Myers Squibb Corporation and Merck & Co Inc.
She serves as a director on the boards of Metabolon Inc. and the North Carolina Biotechnology Center.
Carol holds a M.Sc. degree in Organic Chemistry from the University of New Hampshire, and a B.S. in Chemistry from Merrimack College.
At SRF, John focuses in areas of imaging, computing, photonics, RF communications, and Semiconductors. Before joining SRF in 1999, John co-founded and was CEO of Volumetrics Medical Imaging and was on the founding team of the Digital Signal Processing Division of Analog Devices. John holds several patents in the field of real-time volumetric ultrasound imaging. In addition to continuing as the Chairman of Volumetrics board, John serves on the boards of Astute Networks, Cadtel, Ethertronics, Luminescent, Luxtera, Metabolon, and Scintera. Other Details: Email firstname.lastname@example.org Events Semiconductor Technology: little room left for innovations? MicroVentures 2006 Portfolio Company News Astute Networks Named TechAmerica High Tech Awards Finalist Metabolon awarded series of patents Luxtera, Sun win Darpa optical IC contract GENBAND Nominated to Inc. 500 List of Fastest-Growing Private Companies Ethertronics Ranks on Inc. 500 List for Second Consecutive Year Embedded antennas demystified (ethertronics) Ethertronics buys Swedish antenna design group